FRANCISCO
CASAS MALDONADO
PROFESOR ASOCIADO CIENCIAS SALUD
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, EspañaPublications in collaboration with researchers from Hospital Universitario Nuestra Señora de Candelaria (13)
2024
-
Patient-reported outcome measures in severe asthma: an expert consensus
Journal of Asthma, Vol. 61, Núm. 6, pp. 619-631
2023
-
COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
BMC Health Services Research, Vol. 23, Núm. 1
-
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry
The European respiratory journal
-
Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)
Respiratory Research
-
Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
International Journal of COPD, Vol. 18, pp. 1691-1700
-
What's New in the 2022 Consensus for Severe Asthma in Adults
Archivos de Bronconeumologia
2022
-
Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
Respiratory Research, Vol. 23, Núm. 1
-
Consensus document for severe asthma in adults. 2022 update
Open Respiratory Archives, Vol. 4, Núm. 3
-
Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
ERJ Open Research, Vol. 8, Núm. 3
2020
2016
-
Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients
Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152
2012
2010
-
Tolerance and safety of Trypsone®: Prospective follow-up in alpha-1 antitrypsin deficient subjects with pulmonary emphysema
Minerva Pneumologica, Vol. 49, Núm. 2, pp. 83-91